On 2026-03-30, Lexeo Therapeutics, Inc. (LXEO) announced earnings per share of $-0.27 for the fiscal quarter ending 2025-12-31, beating the average analyst estimate of $-0.32.
The next expected annoucement date for quarterly earnings is 2026-05-11, with an average estimated earnings per share of $-0.29 for the fiscal quarter ending 2026-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-03-30 | 2025-12-31 | $-0.32 | $-0.27 |
| 2025-11-05 | 2025-09-30 | $-0.48 | $-0.33 |
| 2025-08-14 | 2025-06-30 | $-0.64 | $-0.60 |
| 2025-05-12 | 2025-03-31 | $-0.80 | $-0.99 |
| 2025-03-24 | 2024-12-31 | $-0.87 | $-0.78 |
| 2024-11-13 | 2024-09-30 | $-0.65 | $-0.89 |
| 2024-08-12 | 2024-06-30 | $-0.64 | $-0.64 |
| 2024-05-09 | 2024-03-31 | $-0.76 | $-0.77 |
| 2024-03-11 | 2023-12-31 | $-0.71 | $-0.86 |
| 2023-12-11 | 2023-09-30 | $-0.90 | $-12.36 |
| 2023-10-30 | 2023-06-30 | -- | $-8.30 |